Pure Global AI
ANVISA registration 81034870009Active

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 81034870009SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDASCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDARisk Class III
Verified
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
View exact technical-name matches →
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
INVITROCLONE AGH SERUM
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
81034870009
Process Number
25351289130201860
CNPJ
18520715000130
Company information
Registration Holder
SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA
Manufacturer
SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Oct 15, 2018
Status
Active
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81034870009 and manufactured by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA. The registration is held by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA with validity until Oct 15, 2028.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.